0001346302-11-000006.txt : 20111012 0001346302-11-000006.hdr.sgml : 20111012 20111012170723 ACCESSION NUMBER: 0001346302-11-000006 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20111012 DATE AS OF CHANGE: 20111012 EFFECTIVENESS DATE: 20111012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-163075 FILM NUMBER: 111138053 BUSINESS ADDRESS: STREET 1: 3925 WEST BRAKER LANE STREET 2: THIRD FLOOR CITY: AUSTIN STATE: TX ZIP: 78759 BUSINESS PHONE: 512-534-8340 MAIL ADDRESS: STREET 1: 3925 WEST BRAKER LANE STREET 2: THIRD FLOOR CITY: AUSTIN STATE: TX ZIP: 78759 D/A 1 primary_doc.xml X0704 D/A LIVE 0001346302 XERIS PHARMACEUTICALS INC 3925 WEST BRAKER LANE THIRD FLOOR AUSTIN TX TEXAS 78759 512-534-8340 DELAWARE None None Corporation true Yash Sabharwal 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Executive Officer John Kinzel 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Executive Officer Director Doug Baum 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Director Steven Prestrelski 3925 West Braker Lane Third Floor Austin TX TEXAS 78759 Executive Officer Director Other Decline to Disclose 06 true 0001346302-11-000005 2011-07-05 false true true true false 0 1958748 1837848 120900 Series A Preferred Stock Financing and Issuance of Series A Preferred Stock Warrants exercisable at $1.02 per share. false 19 0 0 0 false XERIS PHARMACEUTICALS INC /s/John Kinzell John Kinzell Chief Executive Officer 2011-10-11